Pharma VC Funds

CDP Venture Capital is a leading venture capital firm based in Italy, launched with the goal of accelerating the country's innovation ecosystem. It operates as part of the National Innovation Fund (Fondo Nazionale Innovazione), with the primary aim of fostering the growth of startups across various sectors, including deep tech, medtech, biotech, digital, and more. The firm is driven by the mission to shape Italy's future by investing in high-potential businesses that are transforming strategic industries. CDP manages over €1 billion in assets and works to make venture capital a key pillar of Italy's economic development. The firm invests at various stages, from pre-seed and seed funding to Series A and beyond, with typical investments ranging between €1.5 million and €3 million. Their portfolio includes promising startups such as Empatica, GreenBone, and Mindesk, and they collaborate with national agencies and international partners to support Italy's entrepreneurial growth. A key initiative of CDP Venture Capital is its focus on technology transfer, helping bridge the gap between academic research and commercial success. The firm also actively promotes innovation in areas like AI, web 3.0, and cybersecurity, and it plays a critical role in positioning Italy as a hub for high-tech startups.

Cencora Ventures, formerly known as AB Health Ventures, is the corporate venture arm of Cencora (previously AmerisourceBergen). Launched in 2022, the $150 million fund focuses on investing in early-stage healthcare startups that aim to transform the future of healthcare for both humans and animals. By leveraging Cencora's vast experience and resources, Cencora Ventures offers more than just capital; it actively supports startups with commercialization, distribution, and scalability. The fund is deeply integrated with Cencora’s global pharmaceutical supply chain, allowing it to facilitate connections with healthcare providers, pharmacies, and biotech firms. Cencora Ventures' portfolio includes companies such as SteadyMD, a telehealth infrastructure provider, and Trakcel, which offers solutions for cell and gene therapy orchestration. The fund focuses on areas like digital health, patient management, and decentralized clinical trials, aiming to improve healthcare delivery and outcomes across the globe. With a presence in over 50 countries, Cencora Ventures leverages its parent company’s global network to accelerate the growth of its portfolio companies, offering strategic support such as pilot programs, rapid prototyping, and introductions to a broad customer base. This integration helps emerging companies scale their innovations more efficiently while navigating the complex healthcare ecosystem​.

CDTI (Centro para el Desarrollo Tecnológico Industrial) is a Spanish public business entity under the Ministry of Science and Innovation. It supports technological development and innovation within Spain, mainly by channeling financial and technical assistance to companies working on R&D&I projects. One of its key initiatives, Innvierte, is a venture capital program designed to foster investment in innovative, high-tech startups. Through Innvierte, CDTI co-invests with private capital in technology-based enterprises, targeting sectors like biotech, fintech, artificial intelligence, and digital media. The program has committed over €450 million to co-investment projects and venture capital funds, positioning itself as a critical player in Spain’s innovation ecosystem. CDTI has been involved in significant rounds of funding for companies like Atani, Bdeo, and Odilo. CDTI’s investment approach focuses on supporting early-stage companies with disruptive potential, aiming to bridge the gap between innovation and commercialization. This public-private partnership strategy helps drive Spain’s technology transfer and entrepreneurial growth, supporting industries crucial to the country's economic future.

Centre Street Partners, founded in 2015 and based in New York, focuses on early-stage investments in the technology sector. Their investment strategy targets companies that develop frontier technologies for a rapidly evolving world. Notable investments include Drunk Elephant, Briogeo Hair Care, and Parade, all of which have seen successful exits. The firm invests primarily in the information technology sector, with a diverse portfolio that includes companies like OffDeal, Scream Truck, and Arcee.ai. Centre Street Partners typically invests in seed and early-stage rounds, supporting companies with innovative and scalable solutions. The team is led by General Partners Abie Cohen and Jonathan Kerstein, who bring significant expertise and experience to the firm. Centre Street Partners is committed to partnering with ambitious founders and providing the necessary resources to help their portfolio companies grow and succeed.

CentreStone Ventures is a life sciences-focused private venture capital fund founded in 2004 and based in Winnipeg, Manitoba, Canada — geographically at the center of North America. The firm invests in companies developing early-stage therapeutics, medical devices, diagnostics, and novel drug delivery methods, targeting opportunities with clear unmet clinical needs, solid intellectual property foundations, and the potential to achieve market leadership. CentreStone deploys checks of $500,000 to $3 million at the Seed and Series A stages. Across seven portfolio investments, the firm has achieved three IPOs and one acquisition — a strong exit rate relative to portfolio size that reflects a selective, high-conviction approach to company selection. The small team of three manages a focused book of life sciences companies, prioritizing depth of engagement over breadth of portfolio. The firm appears to be in portfolio management mode rather than actively making new investments, with the most recent investment recorded in 2018. During its active period, CentreStone played a niche institutional role in Canada's healthcare and biotech ecosystem — channeling specialized venture capital into a region that generates significant life sciences research through its university and medical community but has historically had limited access to dedicated early-stage health technology investment capital.

Cercano Management is a venture capital firm spun out from Vulcan Capital, originally established by Microsoft co-founder Paul Allen. Based in Bellevue, Washington, with a new office in Atlanta, the firm focuses on early-stage investments across sectors like technology, consumer, life sciences, and data intelligence. With a patient and methodical approach, Cercano has over two decades of investment experience, boasting a diverse portfolio of more than 120 companies. The firm is particularly active in both the West Coast and Southeast U.S., with an increasing presence in Atlanta to capitalize on early-stage opportunities in emerging markets. Key investments include Group14 Technologies, AdaptX, and Twelve, demonstrating their strong interest in transformative technologies and sustainability ventures. Cercano’s strategy revolves around long-term partnerships, often leading early rounds but maintaining flexibility to support companies through later stages. Their average check size varies, but they are known to lead or co-lead rounds, particularly in seed and Series A investments. Startups looking to engage with Cercano should prioritize demonstrating innovative solutions and a strong growth trajectory. The team, led by CEO Christopher Orndorff and supported by leaders like Daley Ervin in Atlanta and Tommy Teo in Singapore, offers global insights with a deep expertise in scaling tech companies.

CerraCap Ventures, based in Costa Mesa, California, is a global venture capital firm focused on early-stage B2B technology companies. Their key sectors are health tech, enterprise AI, and cybersecurity. Using their unique Sales & Scale™ model, they guide startups through an industrialized process designed to accelerate sales, scale product development, and facilitate successful exits. CerraCap leverages an extensive network of Fortune 500 CXOs to secure early proofs of concept and streamline product adoption. Their investment strategy is geared toward companies that solve real-world problems in healthcare and digital security, with a focus on chronic disease management and securing digital environments. Some notable portfolio companies include Deep Instinct and Dathena, specializing in cybersecurity through AI-driven solutions. CerraCap often leads rounds and provides hands-on support to help startups achieve growth, reduce sales cycles, and gain traction with key customers. The team, led by co-founders Saurabh Ranjan and Saurabh Suri, draws on years of industry expertise to mentor and position companies for success in global markets​.

Change Ventures, founded in 2016 and headquartered in Tallinn, Estonia, is a leading venture capital firm focused on early-stage investments in the Baltic region. The firm has built a strong portfolio with notable investments in companies such as Formaloo, a software development applications firm, and RivalSense, a business productivity software company. They emphasize supporting ambitious Baltic founders across various sectors including aerospace, defense, and hospitality. Change Ventures has made 59 investments to date, demonstrating their commitment to nurturing innovative startups. They have seen successful exits, including Nordigen, a company acquired in 2022. The firm's investment strategy is centered around providing not only capital but also mentorship and strategic guidance to help startups scale effectively. The team at Change Ventures includes experienced professionals like Andris Berzins, who has held C-level roles in successful startups and co-founded TechHub Riga and TechChill. Other key members include Yrjö Ojasaar, a seasoned tech-startup CEO and angel investor, and Rait Ojasaar, an experienced tech entrepreneur and mentor. This diverse team brings a wealth of expertise and a deep understanding of the startup ecosystem in the Baltic region. By leveraging their extensive network and deep industry knowledge, Change Ventures continues to play a pivotal role in the growth and success of early-stage startups in the Baltics​.

Checkmate Capital is a venture capital and strategic advisory firm based in Pasadena, California, with a global reach, including a presence in Seoul, South Korea. Founded in 2017, Checkmate Capital focuses on investments in biotechnology, agriculture and waste technology, energy technology, and diversified technologies. The firm is deeply involved in the sectors it invests in, offering both financial backing and strategic advisory services to help companies grow and succeed. Checkmate Capital's portfolio spans a wide range of industries, including high-tech areas like biotechnology, where they invest in companies developing innovative health solutions, and energy technology, focusing on environmentally friendly and efficient energy solutions. The firm prides itself on its disciplined approach to investment, working closely with companies to create synergies that enhance value across its portfolio. In addition to its investment activities, Checkmate Capital also provides commercial and transaction advisory services, facilitating international licensing opportunities and partnerships that help its portfolio companies expand globally.

Cherry Ventures, founded in 2012, is an early-stage venture capital firm based in Berlin, with additional offices in London and Stockholm. The firm primarily invests in pre-seed and seed-stage startups across various sectors, including fintech, climate tech, consumer products, health tech, mobility, and SaaS. Cherry Ventures is led by partners Filip Dames, Christian Meermann, and Sophia Bendz, all of whom have extensive entrepreneurial experience from building companies like Zalando and Spotify. The firm recently launched its fourth fund at €300 million, focusing on disruptive technologies including crypto and web3. Notable portfolio companies include Infarm, AUTO1 Group, FlixBus, TWAICE, and Cazoo.

Cherubic Ventures is a venture capital firm that specializes in early-stage investments, focusing on transformative industries in both the US and Asia. With over $400 million in assets under management, the firm has a portfolio that includes more than 150 startups. Notable investments include Flexport, Hims & Hers, Calm, Ring, Wish, and Paidy, showcasing their ability to identify and support high-growth potential companies. Founded in 2014 by Matt Cheng, Cherubic Ventures operates from key locations in San Francisco, Taipei, and Beijing. Their investment strategy targets seed-stage companies that have the potential to disrupt industries. They typically invest in sectors such as fintech, health tech, consumer internet, and enterprise software, aiming to back ambitious founders from the earliest stages. Cherubic Ventures is known for its hands-on approach, providing more than just capital. They offer strategic guidance and support to help startups scale. Their active involvement in their portfolio companies has led to successful exits, including high-profile acquisitions and IPOs. The firm’s geographic focus allows them to bridge the gap between Western and Asian markets, providing unique opportunities for startups to expand globally. Cherubic Ventures' team is composed of experienced investors and entrepreneurs who leverage their extensive networks to help startups succeed.

Chicago Ventures is a venture capital firm based in Chicago, focusing on seed-stage investments in technology companies. The firm leads early rounds, often stepping in when other investors might overlook startups. Chicago Ventures has invested in over 100 companies, raising significant follow-on capital since its inception in 2012. Prominent companies in their portfolio include Cameo, SpotHero, project44, and G2. Cameo is known for its personalized celebrity video messages, SpotHero for its parking reservation service, project44 for its logistics technology, and G2 for being the largest software marketplace globally. Other notable investments include HealthJoy, a healthcare guidance platform, and Kin, which simplifies homeowners insurance. Chicago Ventures recently closed its third fund, raising $63 million to continue backing startups that might be initially passed over by other investors. They typically invest between $1.5 million to $2 million per startup and aim to make 25 new investments with this fund. The firm's investment strategy emphasizes a hands-on approach, taking board seats and actively supporting the companies in their portfolio. This approach helps startups navigate their early growth stages and scale effectively.

Chingona Ventures, founded in 2019 by Samara Hernandez and based in Chicago, focuses on early-stage investments, particularly in startups led by women and minorities. The firm emphasizes sectors such as fintech, food technology, health tech, wellness, and the future of work and learning. Chingona Ventures has made significant investments in companies like Career Karma, EarlyBird, and Suma Wealth. The firm recently closed a $52 million Fund II, with contributions from prominent partners including PayPal Ventures and Melinda Gates’ Pivotal Ventures. This fund allows them to increase their typical investment size to between $250,000 and $1 million. The firm is known for backing founders who are often overlooked and operates primarily in the Midwest. Their mission is to support innovative solutions and diverse leadership in the tech industry. The leadership team, including Senior Advisor Sonia Nagar and Associate Grisel Hernandez, brings extensive experience in venture capital and strategic guidance.

CincyTech is a venture capital firm based in Cincinnati, Ohio, focusing on seed-stage investments to drive economic growth and innovation in the Midwest. Founded in 2006, CincyTech has invested in over 140 companies, particularly in the healthcare, technology, and life sciences sectors. Some of their notable investments include Enable Injections, which raised $215 million in Series C funding for their wearable drug delivery devices, and Genetesis, a company that secured $17.5 million to advance their Cardioflux diagnostic imaging platform. Other prominent portfolio companies include ReadySet Surgical, Standard Bariatrics, and NaviStone, which leverage innovative solutions in their respective fields. In 2022, CincyTech reported a record $391 million in co-investments in its portfolio companies, reflecting its significant impact on the regional economy. The firm continues to focus on partnering with visionary founders to transform ideas into world-class companies, supporting them with strategic guidance and access to a robust network of co-investors.

CircleUp Growth Partners, based in San Francisco, is a venture capital firm specializing in early-stage consumer brands. Their data-driven approach is powered by Helio, an advanced platform that provides comprehensive consumer market insights, enhancing the decision-making process for investments and supporting post-funding growth​. CircleUp has backed notable brands such as Halo Top Creamery, Back to the Roots, and Rhythm Superfoods, focusing on sectors like food and beverage, personal care, beauty, pet products, and household consumables​. CircleUp's investment strategy targets companies with revenues between $1 million and $20 million, typically providing growth equity ranging from $1 million to $10 million. They emphasize supporting visionary entrepreneurs who are passionate about their products and have a clear vision for their brands​. The firm is led by a team of experienced partners, including Sam Blumenthal and Karen Howland, who bring extensive backgrounds in consumer investing and operational support​ (CircleUp)​. CircleUp's holistic approach involves not just funding but also leveraging partnerships and community networks to foster collaboration and accelerate growth.

City Light Capital is an early-stage venture capital firm based in New York, focusing on investments that generate measurable social impact in the areas of education, safety and care, and the environment. They believe in leveraging private markets to address complex, intertwined social issues through scalable solutions. City Light invests in companies where financial success is directly tied to social impact, ensuring that growth in revenue equates to better lives at scale. The firm's portfolio includes a diverse array of impactful companies, such as Maven Clinic, Headspace Health, and OhmConnect, which provide solutions ranging from healthcare to clean energy. City Light typically invests between $50,000 and $3 million, often leading or co-leading rounds at the seed stage and beyond. They also have a dedicated seed investment program, City Spark, which nurtures early-stage companies with the potential for significant social impact. City Light's team is composed of experienced investors, including Partners Josh Cohen, Tom Groos, and Jeff Rinehart. They emphasize close collaboration with entrepreneurs to maximize both financial returns and social outcomes. The firm operates primarily in the United States, with a strong presence in major investment hubs like New York and the Midwest.

Civilization Ventures is a venture capital firm founded in 2017 with a strong focus on health tech and biology innovations. Based in Silicon Valley, the firm has grown from a $1M pilot seed fund to managing over $100M in capital. They have invested in over 60 companies across genomics, diagnostics, digital health, and synthetic biology, emphasizing preventative, personalized, and regenerative healthcare solutions. Notable investments include Rocket Pharma, which focuses on gene therapies for rare diseases, and Singular Bio, acquired by Invitae to enhance genetic screening in early pregnancy. Other significant exits include Lemonaid Health, acquired by 23andMe, and Rewrite, a gene editing company acquired by Intellia. The team at Civilization Ventures is composed of experienced biopharma executives and operators who have founded and sold companies. They support founders through a vast network and their extensive experience in the field. Additionally, they offer a unique fellowship program to train PhDs to become future entrepreneurs in the life sciences sector.

Claris Ventures is an Italian venture capital firm established in 2019, focusing on early-stage investments in high-potential biopharma companies. The firm's first fund, Claris Biotech I, targets innovations that are poised to enter clinical trials within 12 to 24 months. Claris Ventures is particularly interested in therapeutic areas such as oncology, immunology, and rare diseases—sectors that often have significant unmet medical needs. The firm's strategy involves not only providing capital but also offering hands-on support in areas like project management, finance, and strategic development, allowing scientific founders to focus on their research and development. Claris Ventures aims to build value around strong scientific evidence, with a mission to make a substantial impact on patient care. Claris Ventures leverages Italy's robust R&D ecosystem, drawing from local research centers, clinical institutions, and international collaborations. The team, led by Managing Partners Pietro Puglisi and Ciro Spedaliere, includes experienced professionals who are committed to guiding portfolio companies through the critical early stages of development. Some notable companies in their portfolio include NeoPhore, Resalis Therapeutics, and Kither Biotech, which are all working on breakthrough therapies in their respective fields.

Clave Capital is a prominent venture capital firm based in Pamplona, Spain, with a strong focus on the healthcare sector. Notable for their recent €50 million Clave Innohealth fund, they target high-growth potential startups across Europe, specifically in medtech, digital health, health-nutrition, and biotech sectors. Clave Capital’s portfolio includes promising startups like Innitius, which focuses on improving diagnostics for women’s health. Clave Capital primarily invests in early-stage to Series A funding rounds, with initial contributions ranging from €500k to €1 million, and potential follow-on investments up to €3 million per project. Their geographic focus extends throughout Spain and Europe. The firm’s investment strategy emphasizes not only financial backing but also active involvement in the growth and development of their portfolio companies. They maintain close relationships with research centers and hospitals, providing valuable expertise and connections to foster innovation. Clave Capital's experienced team, led by Chairman and CEO José Javier Armendariz and Director of Funds Santiago Lozano, has a track record of over 20 years and 90 investments, which positions them as a significant player in the European healthcare investment landscape. For startups looking to engage with Clave Capital, it’s advisable to highlight innovative potential and market leadership capabilities in the healthcare domain. Their preference for hands-on involvement means that demonstrating a collaborative approach could be beneficial.

Clay Capital, formerly known as VisVires New Protein, is a Singapore-based venture capital firm focused on agrifood technology. In 2023, the firm closed its second fund at $145 million, signaling a strong commitment to transforming the food and agriculture sectors. Clay Capital backs innovative startups across Europe, Asia, and Israel that are working to create sustainable and regenerative food systems. Its investment strategy targets technologies that address key issues like food security, sustainability, and environmental health. With initial investments ranging from $3 million to $8 million, Clay Capital supports startups working on solutions in areas such as regenerative agriculture, crop disease resistance, and sustainable packaging. The firm’s portfolio includes companies like Toopi Organics, which repurposes human urine as a bio-stimulant, and In Ovo, which develops sex determination technologies to reduce the culling of male chicks in the poultry industry. Clay Capital’s approach emphasizes connecting the Asian and European markets, leveraging its expertise and network to help startups expand globally. This cross-continental strategy reflects the firm’s vision of creating a healthier and more sustainable food system while fostering innovation in agrifood tech.

Clean Growth Fund (CGF) is a pioneering £101 million venture capital fund launched in 2020, dedicated to supporting early-stage clean technology companies in the UK. Backed by cornerstone investors such as CCLA and the UK government, CGF focuses on startups that are developing innovative solutions to reduce carbon emissions across critical sectors like power, energy, transport, buildings, and agriculture. The fund’s primary mission is to drive superior financial returns while accelerating the transition to a low-carbon economy, directly contributing to the UK’s Net Zero targets by 2050. CGF typically makes initial investments ranging from £500k to £3 million, primarily during Seed and Series A rounds, and plays an active role in scaling these companies. The fund’s portfolio reflects its commitment to high-impact climate tech, featuring companies like Sunswap, which has developed a zero-emission transport refrigeration unit that can reduce emissions by up to 93%, and Holiferm, a University of Manchester spinout producing eco-friendly biosurfactants for consumer products. Under the leadership of Managing Partner Beverley Gower-Jones, who has over 30 years of experience in clean tech and energy, CGF leverages deep industry expertise to provide more than just capital. The firm actively supports its portfolio companies in achieving their business goals, thus ensuring their innovations make a significant contribution to reducing global carbon emissions. CGF’s strategy aligns with its investors' goals, particularly those managing large funds like the South Yorkshire Pensions Authority and Aviva Investors, who are committed to integrating climate solutions into their portfolios​.

Cleo Capital is a venture capital firm founded in 2018 by Sarah Kunst, based in San Francisco, California. The firm focuses on early-stage investments, primarily targeting the pre-seed and seed stages. Cleo Capital is particularly committed to backing companies in sectors such as fintech, healthtech, web3, and the creator economy, with a key focus on three main investment theses: the Future of Income, Complicated Consumer, and Decentralized Enterprise. Cleo typically invests between $100K to $1M in startups with high growth potential, particularly those building software with the potential to become multi-billion-dollar enterprises. The firm has invested in over 40 companies, including notable startups like Ellevest, Kobold Metals, Hill House Home, and FalconX. As a general partner, Sarah Kunst is recognized as one of the top innovators in venture capital and has been involved in initiatives like Bumble Fund, advising underrepresented founders. Cleo Capital also places a strong emphasis on supporting entrepreneurs with long-term guidance and creating value within its portfolio.

Cleveland Avenue, founded in 2015 and based in Chicago, Illinois, is a venture capital firm that invests in lifestyle consumer brands and technology companies. The firm is dedicated to accelerating growth for entrepreneurs by providing not only financial resources but also strategic support across various business functions. Cleveland Avenue focuses on several sectors including food and beverage, AgTech, consumer goods, and health and wellness. Their portfolio includes innovative companies like Farmer’s Fridge, a vending machine company providing fresh meals; PreciTaste, an AI-enabled foodservice management platform; and Hero, a producer of zero-carb, zero-sugar foods made from plant-based proteins. The firm's approach goes beyond passive investment. They offer a range of services such as financial expertise, organizational development, marketing, supply chain optimization, and operational guidance to help their portfolio companies succeed. Their state-of-the-art Innovation Facility in Chicago serves as a hub for R&D, consumer research, and product showcases. Key figures at Cleveland Avenue include Don Thompson, the CEO, who leverages his extensive experience in corporate leadership to guide the firm's strategic vision, and Joseph McCoy, the COO and General Counsel, who brings a wealth of experience in legal and business transactions.

Climate Capital is an early-stage venture capital firm focused on investing in climate tech startups. Founded in 2018 by Sundeep Ahuja, Climate Capital aims to address climate change through strategic investments in innovative technologies that reduce emissions and promote climate adaptation. The firm supports over 350 teams working on various solutions, including clean energy production, carbon emission reduction, and sustainable lifestyle transformations. Climate Capital operates multiple funds and syndicates, such as the Seed, Growth, Bio, and Climate Scout Fund. This platform approach allows the firm to build expertise across specific verticals and leverage efficiencies of scale. The firm provides founders access to a wide network of partners, resources, and LPs to accelerate growth. Their portfolio includes companies like Mosaic, Moxion Power, and Ampaire, showcasing their commitment to diverse climate solutions. Climate Capital is highly networked, with over 2,500 climate investors, founders, operators, and enthusiasts in their community. This extensive network helps founders find talent, customers, strategic partners, and additional investors.

Climentum Capital is a Copenhagen-based venture capital firm launched in 2022, focused on investing in early-stage European climate tech startups that are driving significant CO2 reductions. The firm is particularly known for its commitment to "hard-tech" solutions—innovations that combine hardware and deep technology to address major industrial challenges. Climentum Capital invests primarily in Seed and Series A rounds, with typical investments ranging from €1 million to €5 million. The firm's investment thesis centers on six key sectors: Next Generation Renewables, Food & Agriculture, Industry & Manufacturing, Buildings & Architecture, Transportation & Mobility, and Waste & Materials. With offices in Copenhagen, Berlin, and Stockholm, Climentum has a strong presence in the Nordics and the DACH region, areas known for their leadership in sustainability and industrial innovation. Climentum Capital operates as an Article 9 fund, which under the EU's Sustainable Finance Disclosure Regulation (SFDR) means that all of its investments must have a measurable positive impact on the environment. The firm uses a dual carry structure, linking financial returns with CO2 emissions reduction goals to ensure that both economic and environmental objectives are met. In 2024, Climentum announced plans to launch a second fund, targeting €100 million to continue its mission of supporting high-impact climate tech startups across Europe. The firm has already made significant investments in companies like Qvantum and Novatron Fusion, which are developing next-generation heat pumps and fusion reactors, respectively​.

Coatue Management is a top-tier venture capital firm renowned for its investments in transformative technology companies. With notable investments in industry giants like ByteDance, Niantic, Airtable, and DoorDash, Coatue's portfolio is diverse and impressive. They focus primarily on sectors such as fintech, enterprise software, healthcare, and AI, investing globally with a strong presence in the U.S., Europe, and Asia. Coatue operates across multiple investment stages, from early-stage venture capital to growth equity and public markets. Their strategy involves deploying significant capital swiftly to capture emerging opportunities, with investments ranging from $10 million to over $100 million. They are known for their agility and ability to provide strategic support and resources to their portfolio companies. Led by founder Philippe Laffont and his brother Thomas Laffont, the team includes heavy-hitters like Dan Rose, a former VP at Facebook, and enterprise investment experts Jade Lai and Nina Gerson. They have offices in New York, Menlo Park, Los Angeles, London, and Hong Kong, reflecting their global reach. Coatue prefers startups to approach them through their network, valuing introductions that demonstrate a strong product-market fit and the potential for significant impact. The firm is highly active, often leading funding rounds and providing ongoing support to help their companies scale​.

Cocoon Capital, founded in 2016 by William Klippgen and Michael Blakey, is a venture capital firm based in Singapore. The firm focuses on seed and early-stage investments in enterprise and deep-tech startups across Southeast Asia. Cocoon Capital has a strong track record of helping startups achieve significant growth, maintaining close relationships with Series A and B funds in the region to facilitate future funding rounds​. Their portfolio includes innovative companies such as See-Mode Technologies, BuyMed, SensorFlow, and Lendela. These startups span various industries including medtech, logistics, financial software, and sustainability. Cocoon Capital's approach involves providing substantial support to founders, acting as trusted advisors and helping them navigate early-stage challenges to achieve product-market fit and scale their businesses. Cocoon Capital has made 55 investments and has had successful exits with companies like JazzyPay and FoodRazor. They focus on investing in a limited number of startups each year, allowing them to dedicate ample time and resources to each portfolio company. This hands-on model has led to a high success rate, with over 70% of their portfolio companies progressing to Series A funding.

CofounderZone is a Warsaw-based early-stage venture capital fund focusing on tech startups across Central and Eastern Europe. Its portfolio includes companies in AI, IoT, software, and automation, with a preference for B2B and B2G models. Notable investments include EcoBean, Foodsi, and Aleet. CofounderZone typically targets pre-seed and seed-stage startups, providing both capital and strategic support to propel growth. The firm is particularly active in sectors like clean tech, digital health, and fintech. CofounderZone operates with a unique model that combines angel investors and established entrepreneurs. This network offers startups deep expertise in business strategy and execution. The fund’s investment strategy emphasizes minority stakes, and it has been involved in some key rounds, including Aleet's $1.25M pre-Series A. Founders Tomasz Goliński, Ph.D., and Michał Sioda, CFA, lead the fund’s operations with extensive backgrounds in finance, corporate restructuring, and technology ventures. Their focus is on hands-on partnerships, with a strong interest in innovation-driven solutions. For startups looking to connect, CofounderZone values personalized approaches that highlight the startup’s potential for scalability and technological innovation. They are a dynamic presence in the region, steadily building a diverse investment portfolio.

Collab Capital is an Atlanta-based venture firm founded in 2020 with a mission to empower Black entrepreneurs by bridging the venture capital funding gap. Co-founded by Jewel Burks Solomon, Barry Givens, and Justin Dawkins, the firm focuses on investing in Black-owned startups, providing both capital and strategic guidance to help them grow sustainably. Their unique investment approach combines profit-sharing and equity, offering an alternative to traditional VC models, which helps founders retain more control of their businesses. With an inaugural $50 million fund, Collab Capital aims to support around 50 companies over the next few years, targeting industries like fintech, healthcare, and media. Some of their notable portfolio companies include Goodr, a sustainable food waste management platform, Hairbrella, an innovative weather-resistant headwear brand, and Jax Rideshare, which provides car rentals for gig economy workers. Their investments typically range from $500,000 to $2 million, prioritizing startups in underserved regions such as Atlanta, DC, Baltimore, and Detroit. Collab Capital’s broader goal is to foster generational wealth and economic equality by backing Black innovation and ensuring founders have the resources to scale their businesses without sacrificing ownership.

Collaborative Fund, founded in 2010 by Craig Shapiro, is a venture capital firm focused on supporting entrepreneurs and ideas that push the world forward. The firm primarily invests in early-stage companies across various sectors, including next-gen consumer products, climate solutions, industrial transformation, food innovation, and precision health. Some of their notable investments include Beyond Meat, Lyft, Impossible Foods, and Sweetgreen. The firm recently raised $200 million for two new funds: Collaborative V and Collaborative Growth. Collaborative V focuses on early-stage investments, while Collaborative Growth targets more established startups looking to scale​. Collaborative Fund's investment philosophy emphasizes sustainability, social impact, and innovative solutions that address global challenges.

Colle Capital is a global, early-stage venture fund known for its opportunistic approach. Led by founder Victoria Grace, Colle focuses on sectors such as logistics, fintech, healthcare, and advanced technology, often backing companies with strong data-driven models. Key investments include notable names like Maven Clinic, Hyliion, LiquidPiston, and MarketMuse, highlighting its diverse portfolio from digital health to AI. Based in New York, the fund does not limit itself geographically, investing across the U.S., Europe, and emerging markets. Colle Capital primarily targets seed to Series A stages, with a flexible strategy that includes both leading and co-investing in rounds. They’re known for writing checks ranging from $1M to $5M depending on the company’s potential and sector. Victoria Grace, with her background in private equity and investment banking, emphasizes supporting innovative startups with scalable impact. Colle looks for strong founders and products with a clear path to commercialization. Startups seeking to pitch should focus on data integrity, market scalability, and strategic vision, as these are critical criteria for the fund. Colle remains active in sectors with strong network effects and emerging technologies.

Collide Capital is a $66M venture fund focused on empowering diverse founders tackling global challenges. Led by Aaron Samuels and Brian Hollins, who co-founded AfroTech and BLCK VC, Collide Capital invests primarily in early-stage companies across enterprise SaaS, supply chain infrastructure, and consumer technology, with a particular emphasis on startups led by Black, Latinx, and female founders. The firm has built a notable portfolio that includes companies like Rheaply, Golde, Sidechat, and Slang.ai. With backing from major institutions like Amazon, Alphabet, and Twitter, Collide Capital is dedicated to leveling the playing field by directing resources to underrepresented entrepreneurs. They invest from pre-seed to Series A, typically leading rounds, and offering not just capital but hands-on support through a strong network of industry connections. The average check size varies but tends to be smaller early on, allowing Collide to guide startups to later stages. Based in New York, the Collide team blends deep operating and investing experience. Their mission is not only to fund the next generation of diverse founders but also to transform the venture capital landscape by making diversity and inclusion a cornerstone of innovation. Startups are encouraged to approach the firm via their website’s pitch portal, emphasizing alignment with Collide’s vision of impactful, intersectional innovation.

Colopl Next is a venture capital arm of Colopl Inc., a prominent Japanese gaming company, founded in 2015. Colopl Next focuses on investing in startups and publicly listed companies, with a strong emphasis on emerging technologies, B2C services, and the entertainment sector. The firm leverages its extensive knowledge in these areas to support young entrepreneurs and innovative companies globally. The fund's industry focus includes virtual reality (VR), augmented reality (AR), artificial intelligence (AI), blockchain, and other cutting-edge technologies. Notable investments include companies like Flitto and Kaizen Platform, which have successfully gone public. Colopl Next also has a robust presence in sectors like lifestyle services, health, and media content, supporting ventures that align with the theme of "Entertainment in Real Life". Geographically, Colopl Next primarily operates from Tokyo, Japan, but it also invests in international startups, including those in Korea and Southeast Asia. Their investment strategy includes a range of funds, such as the Next Unicorn Fund and several others dedicated to different stages and focuses, from seed investments to more mature stages. Colopl Next is known for its hands-on support approach, providing extensive resources through a network of over 200 portfolio companies, numerous advisors, and experts. This support is augmented by the diverse backgrounds of its team members, including former investment managers and successful entrepreneurs. The leadership team at Colopl Next includes key figures like Naruatsu Baba and Sehong Jang, who bring substantial experience and strategic vision to the firm. Startups seeking investment from Colopl Next are encouraged to showcase innovative technologies and robust growth potential​.

Comcast Ventures, established in 1999 and headquartered in New York, is the corporate venture capital arm of Comcast Corporation. The firm focuses on early to growth-stage investments across various sectors, including digital health, energy, fintech, future of work, and proptech. Leveraging the resources and network of Comcast NBCUniversal, Comcast Ventures aims to help its portfolio companies accelerate growth and achieve meaningful impact. Some of Comcast Ventures' notable investments include Slack, Nextdoor, Instacart, and DocuSign. These investments highlight the firm's focus on companies that drive innovation and shape the future of their respective industries. Recently, Comcast Ventures has made investments in companies like SafeBase, Hume, and HealthSnap, showcasing its commitment to supporting technology-driven solutions in healthcare and AI. The firm is led by a team of experienced partners, including Managing Partner Allison Goldberg, who plays a key role in guiding their investment strategy. Comcast Ventures' approach combines the agility of a venture fund with the strategic insights of a corporate investor, providing a comprehensive support system for startups.

Commonweal Ventures is an early-stage venture capital firm focusing on companies at the intersection of technology and public policy. The firm targets sectors such as clean energy, healthcare, financial services, transportation, and infrastructure, aiming to support startups positioned to capitalize on shifts in government regulations and public investments. Their typical investment ranges from $250K to $2M, participating in pre-seed through Series A rounds, often leading or co-leading. Founded by Nate Loewentheil, a former Obama White House official with extensive experience in infrastructure and technology, Commonweal backs startups with the potential to drive large-scale societal improvements. Notable portfolio companies include firms advancing sustainability and urban revitalization efforts​. The firm is deeply involved in helping companies navigate the evolving policy landscape to unlock growth opportunities. Their team consists of key figures from both the public and private sectors, including General Partner Ron Bloom, a former senior advisor in the U.S. government. This diverse leadership enables Commonweal to provide not only capital but also strategic guidance in areas heavily influenced by regulation.

Compound is a thesis-driven, research-centric investment firm that focuses on early-stage investments across deeply technical and science-driven areas. The firm is dedicated to accelerating the futures envisioned by its founders, helping them solve complex technical problems, communicate breakthroughs, and scale commercialization efforts. Founded by Michael Dempsey, Compound has a diverse team of investors, researchers, and operators with extensive domain expertise. Notable team members include General Partner David Hirsch and Venture Partners like Celeste Holz-Schietinger, who has a background in biology and was instrumental in creating plant-based meat products at Impossible Foods. Compound's portfolio is broad, encompassing sectors like AI/ML, robotics, healthcare, biology, and crypto. Notable investments include companies such as Deepgram, Hyphen, Arbitrum, and Dapper Labs. The firm emphasizes a hands-on approach and leverages its network and prior experiences to support the growth and success of its portfolio companies.

Connect Ventures, established in 2012 and based in London, is a venture capital firm that focuses on early-stage investments in Europe. The firm is particularly interested in product-led founders and companies that leverage emerging technologies to create or disrupt large markets. Connect Ventures has a diverse portfolio, including notable investments like Citymapper, an urban navigation app; Typeform, an online survey platform; and Curve, a fintech company that consolidates multiple bank cards into one. Recent investments also include Metomic, which helps businesses detect and control sensitive data in cloud applications, and Sprinque, a B2B checkout solution with embedded trade finance​. The firm typically invests in seed and Series A rounds, with initial check sizes ranging from €500,000 to €3 million. Connect Ventures aims to provide not just capital but also strategic guidance and support, helping startups scale and succeed in competitive markets. They are known for their hands-on approach and commitment to partnering with founders through every stage of growth.

Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm, dedicated to supporting the state's innovative and high-growth companies. Founded in 1989, CI invests across various industries, including biotech, IT, cleantech, and advanced manufacturing. They manage several funds, including the $50 million Future Fund, which targets early-stage, tech-enabled startups with diverse teams, emphasizing underrepresented founders. Investment sizes range from $250,000 to $1.5 million. Notable investments from CI’s diverse portfolio include companies like Athletic Brewing, Budderfly, and Veradermics. The firm’s commitment to diversity is further highlighted by the ClimateTech Fund, a $100 million initiative to support climate and adaptation technology ventures aimed at decarbonization and job creation in Connecticut​. Leading the team is CEO Matt McCooe, who brings over 25 years of venture capital experience. Key team members also include Alison Malloy, Managing Director of Investments, who co-manages the Future Fund, and Konstantine Drakonakis, Managing Director for the ClimateTech Fund. Connecticut Innovations prioritizes companies that are willing to maintain a presence in Connecticut, leveraging co-investment opportunities to maximize growth potential and support from a network of experienced partners and advisors. Their holistic approach involves strategic guidance, financial backing, and extensive networking opportunities to ensure portfolio companies thrive

Conscience VC is an early-stage venture capital firm that focuses on funding innovative startups aiming to make a positive impact on the world. Founded in 2020 by Ariana Thacker, the firm is headquartered in Austin, Texas. Conscience VC invests primarily in the intersection of consumer and science, with a particular emphasis on sectors such as biotechnology, digital health, clean tech, and other socially responsible industries. The firm is notable for its commitment to diversity and inclusion, with over 50% of its portfolio companies led by female and diverse founders. Ariana Thacker, the driving force behind Conscience VC, is a passionate advocate for underrepresented groups in the venture capital space, leveraging her technical background in chemical engineering to support groundbreaking companies. Conscience VC has made 14 investments to date, including companies like Aqua Cultured Foods and Somite Therapeutics, and continues to prioritize Environmental, Social, and Governance (ESG) principles in its investment strategy.

Conscious Venture Lab (CVL) is a Baltimore-based accelerator focused on supporting early-stage, purpose-driven startups that are committed to using innovation to tackle societal challenges. Launched in 2013, CVL operates a four-month immersive program designed to help founders build businesses that balance profit with a social mission. CVL specifically seeks out underrepresented and diverse entrepreneurs who are passionate about creating equitable solutions, with a focus on sectors like big data, IoT, cleantech, and cybersecurity. With a curriculum centered around stakeholder capitalism, CVL emphasizes the importance of fostering businesses that deliver value not only to shareholders but also to communities and the environment. Founders gain access to mentorship, strategic guidance, and a broad network of investors and industry leaders. The lab's portfolio includes companies like EcoMap Technologies, which focuses on democratizing data access, and other tech-driven ventures that address food security, climate resilience, and urban innovation. CVL, led by founder Jeff Cherry, has a hands-on approach to helping startups scale, providing a support system that ranges from early seed funding to Series A investments. Startups in the program benefit from connections to thought leaders and strategic partners, including both financial and governmental institutions​.

Consilience Ventures is a London-based venture capital firm founded in 2018 by Kevin Monserrat, headquartered at Moorgate Place in the City of London. The firm focuses on deep technology startups at the earliest stages — idea through seed — with a particular emphasis on AI, healthcare, medtech, and cybersecurity across Europe. Consilience's model is distinctive in its use of tokenized equity to align startups, investors, and domain experts, with a stated mission to fast-track the development of 1,000 deep tech businesses worldwide over 10 years. The firm deploys checks of $200,000 to $500,000 across seven investments to date, including QV Bioelectronics in therapeutic devices, CheckStep in content moderation technology, and Jiva.ai in AI-powered healthcare. Consilience operates a curated network of more than 300 industry specialists who provide active expert guidance to portfolio companies, spanning the UK, Germany, Austria, France, Italy, Switzerland, and Spain. Councilience's value-add model rests on structured expert access rather than generalist mentorship. Each portfolio company goes through a gap analysis process designed to identify specific operational and strategic deficiencies, then gains targeted support from the specialist network. This systematic approach to non-capital value creation — combined with technology-enabled equity structures — reflects the firm's thesis that scaling deep technology requires more than funding: it requires the right technical and commercial expertise at the right moment.

Continental Grain Company, also known as Conti, is a privately-owned global investor with a rich history spanning over 200 years in the food and agribusiness sectors. Founded in 1813, the company operates across North America, Latin America, Asia, and Europe, making investments that cover the entire food supply chain, from production to processing and distribution. Conti's investment strategy focuses on leveraging its deep industry expertise, flexible capital, and extensive partnership network to build businesses that create long-term value. This includes backing early-stage growth companies that use cutting-edge technology to innovate within the agrifood space. Notable investments in their portfolio include Pivot Bio, Brightseed, and Bushel, which are leading advancements in ag biotech, digital infrastructure, and alternative proteins. In recent years, Continental Grain has expanded its footprint through significant acquisitions and partnerships. For example, the company formed a joint venture with Cargill to acquire Sanderson Farms, creating Wayne-Sanderson Farms, a major U.S. poultry business. This move underscores Conti's commitment to scaling its operations and maintaining a strong presence in the food production sector​.

Contrary, founded in 2016 and headquartered in San Francisco, focuses on identifying and investing in top entrepreneurial talent from the seed stage through to scaling. The firm has a portfolio that spans various industries, including technology, healthcare, and financial services. Notable investments include Zepto, an on-demand grocery delivery service in India, and Ramp, a finance automation platform designed to streamline business expenses. Other significant investments are in companies like Orchard Robotics, which focuses on precision agriculture, and Memora Health, an operating system for care delivery. Contrary's investment strategy revolves around a talent-driven approach, supporting exceptional entrepreneurs with not just capital, but also strategic and operational guidance. The firm has made 87 investments and has been involved in significant exits like Rubrik and Aryeo. The leadership team, including founder Eric Tarczynski and partners like Jason Chen and Will Robbins, brings a wealth of experience in venture capital and startup growth. Contrary emphasizes building a strong community of founders and leveraging a robust network to support portfolio companies.

Coronis Medical Ventures is a venture capital firm based in Milpitas, California, focusing on early-stage investments in the medical device sector. Established in 2006, it operates as both a seed fund and a business accelerator, supporting startups in fields such as cardiovascular, neurovascular, and minimally invasive therapeutic devices. Coronis is known for providing capital, prototyping support, and hands-on development to help medical companies bring their innovations to market. With notable investments in companies like Varix Medical and VasoNova, Coronis typically leads at the seed stage, helping startups achieve proof of concept before seeking larger follow-on funding for commercialization. The firm's leadership includes veteran medical device entrepreneurs, including Mark Klopp and Roger Stern, who bring extensive industry experience​. Coronis has made a significant impact by combining venture funding with practical guidance and strategic leadership, positioning itself as a key player in medical technology innovation​.

Correlation Ventures, founded in 2006 and based in San Francisco, leverages predictive analytics to make investment decisions, positioning itself as a unique player in the venture capital landscape. With over 519 investments, the firm has backed notable companies such as IonQ, MosaicML, Imperfect Foods, and Personal Capital. Their innovative approach allows them to make rapid investment decisions, typically within two weeks, without traditional due diligence, making them a preferred co-investor for many lead venture capitalists​​. Correlation Ventures typically invests between $1 million and $4 million, focusing on diverse sectors including AI, fintech, healthcare, and consumer products. Their portfolio is characterized by a high level of diversification, including early investments in companies that have achieved significant exits such as Synthorx, which was acquired by Sanofi for $2.5 billion, and Personal Capital, acquired by Empower for $875 million​​. The firm was co-founded by David Coats and Trevor Kienzle, who continue to lead the team alongside key figures like Wesley Barrow and Grace Chui-Miller. With offices in San Francisco, San Diego, and New York City, Correlation Ventures continues to expand its influence by applying data-driven insights to support its investment strategy and portfolio growth​.

Cosmic Venture Partners, founded in 2021 and based in New York, is an early-stage venture capital firm. The firm focuses on investing in next-generation startups, particularly those operating in the tech, Web3, and consumer packaged goods (CPG) sectors. Cosmic Venture Partners aims to support innovative platforms, products, and services that have the potential to transform their respective industries. The firm was co-founded by Alexandra Tynion, Brian McNamara, and Matthew Rutler. Alexandra Tynion, who has experience with SeedInvest and Circle Financial, is based in New York City. Brian McNamara, with an MBA from Columbia Business School and a background at Jefferies, operates out of Austin, Texas. Matthew Rutler, an angel investor in over 100 startups and an EVP at MasterClass, is based in Los Angeles. Cosmic Venture Partners has made several notable investments, including GarageXYZ in the automotive sector and Goodles in food products. The firm has also achieved successful exits, such as the buyout of Nue Life and the acquisition of Kangaroo​. The firm's ethos centers on partnering with visionary founders who are not only imagining the future but actively building it. Cosmic Venture Partners provides both capital and strategic support, leveraging their extensive network and industry expertise to help startups scale and succeed.

Cota Capital, founded in 2015 and based in San Francisco, is a multi-stage investment firm focusing on enterprise technology. The firm aims to support companies through both private and public investments, leveraging a strategic and operational approach to drive growth. Cota Capital invests in sectors such as AI, cloud computing, fintech, and cybersecurity, with notable portfolio companies including OpenGov and Mission Bio. Led by founder Bobby Yazdani, Cota Capital emphasizes a partnership model, working closely with portfolio companies to build long-term value. Their investment range typically covers early to growth stages, providing substantial support to innovative ventures​.

Cottonwood Technology Fund is a venture capital firm specializing in seed and early-stage investments in technology-driven businesses. With offices in Santa Fe, New Mexico, and Enschede, the Netherlands, the fund focuses on sectors such as chemistry and material sciences, photonics, robotics, medical technology, and clean energy. Their investment strategy targets hard science and deep tech startups, providing crucial support for commercialization and global scaling. Notable investments include companies like Skorpios Technologies, BayoTech, Respira Therapeutics, Infinitum Electric, and Exagen. Cottonwood is known for its hands-on approach, offering more than just financial backing by actively helping with strategy alignment, market entry, and connecting portfolio companies with potential customers and strategic partners. The firm’s team, led by Managing Director Dave Blivin and General Partner Alain le Loux, brings diverse expertise and a strong entrepreneurial mindset, making Cottonwood a valuable partner for startups in their portfolio.

Coughdrop Capital is an early-stage venture capital firm founded by brothers Stu and Austin Smith in 2015. Based in Bend, Oregon, with a presence in San Francisco and Los Angeles, the firm typically invests $25-50K in pre-seed and seed-stage startups across various sectors. Their investment philosophy centers on backing smart, ambitious founders regardless of the industry​. The firm has a diverse portfolio that includes notable investments in companies such as Superhuman, Lattice, Mercury, Ware, Dreamship, Ever Loved, Housable, Fast, and Catch. Coughdrop Capital is known for its founder-friendly approach, often providing strategic guidance, valuable introductions, and operational support to its portfolio companies​. Stu Smith brings extensive experience from his roles at WarnerMedia and Teespring, focusing on driving innovation in the entertainment and media sectors. Austin Petersmith, on the other hand, is the founder and CEO of Capiche, a platform for honest conversations about SaaS, and has a background in growth and marketing roles at early-stage startups​. Coughdrop Capital's investment strategy emphasizes quick decision-making and maintaining a supportive relationship with founders. They have been praised for their helpfulness, integrity, and ability to stay out of the way when not needed, while being available to offer support and resources when required.

Courtside Ventures is a leading early-stage venture capital firm specializing in sports, lifestyle, and gaming investments. Founded by Vasu Kulkarni, the firm is headquartered in New York City. Courtside has a strong portfolio, including notable companies like The Athletic, StockX, and 100 Thieves. Their focus is on businesses at the intersection of sports, media, and technology, reflecting a keen interest in the content creation, distribution, and monetization spaces. With three funds totaling over $200 million in assets under management, Courtside Ventures has made over 80 active investments. They typically participate in Seed and Series A rounds, often leading the funding efforts. The firm’s geographic focus spans both the U.S. and international markets, with about 20% of their investments located outside the U.S. Courtside Ventures employs a strategic approach, prioritizing startups that can demonstrate significant potential in their niche markets. They look for passionate entrepreneurs and innovative business models that can drive growth in sports tech, wellness, and gaming. Noteworthy team members include Vasu Kulkarni, Deepen Parikh, and Kai Bond, each bringing extensive experience and a deep network in their respective fields. For startups seeking to connect with Courtside Ventures, it's crucial to present a clear vision aligned with the firm’s core investment themes. They appreciate pitches that highlight unique value propositions and scalable business models that can thrive in the ever-evolving landscape of sports, lifestyle, and gaming.